← Screener

PODD Insulet Corporation

Healthcare

Price
$144.62
Intrinsic value
$100.04
Buy price
$80.03
Discount
-44.6%
Overvalued

DCF walkthrough

Near-term growth (g1)25.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$511,200,000.00
Total debt
$948,400,000.00
Cash & STI
$534,900,000.00
Shares out.
69,403,000
Overvalued
Intrinsic value$100.04
Buy price (with MOS)$80.03
Current price$144.62
Discount to intrinsic value-44.6%

7-step quality scorecard

ROE quality
HIGH_VOLATILE
Average ROE
20.0%
Current ROE
16.3%
Minimum ROE
1.0%
Debt quality
MODERATE
Debt / Equity
0.63x
Moat proxy
MODERATE_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.36x

Technical chart

Confluence: DOWNTREND (0/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.

Assumptions & data quality

Data source
yfinance
Growth (g1) source
revenueCAGR
Valuation model
DCF_OCF
Debt as % of DCF PV
12.9%
Public economic interest
100.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.